The use of SGLT-2 inhibitors and hemoconcentration in patients with heart failure

Back

HFA Premium Access

The use of SGLT-2 inhibitors and hemoconcentration in patients with heart failure

Session: ePosters in chronic heart failure - pharmacotherapy 2

Topic: Pharmacotherapy

Speaker: Doctor H. Unlugenc (Izmir, TR)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Hazal Unlugenc

Ege University Hospital, Izmir (Türkiye)

1 presentation

1 follower

7 more presentations in this session

Quality of care among patients with heart failure with reduced ejection fraction at an outpatient setting in a tertiary center

Speaker: Doctor K. Enriquez (Manila, PH)

The difference in the use of guideline-directed medical therapy in patients hospitalised for heart failure managed by cardiologists and non-cardiologists

Speaker: Doctor T. Furlan (Trbovlje, SI)

Use of guideline-directed therapy in patients hospitalised at a general internal medicine ward

Speaker: Doctor T. Furlan (Trbovlje, SI)

Did we forget ARNI in the era of SGLTi?

Speaker: Doctor T. Cikara (Zagreb, HR)

Aspiring for precision: tailoring medication titration in heart failure patients

Speaker: Doctor J. Santos Fonseca (Lisbon, PT)

Access the full session

ePosters in chronic heart failure - pharmacotherapy 2

Speakers: Doctor H. Unlugenc, Doctor K. Enriquez, Doctor T. Furlan, Doctor T. Furlan, Doctor T. Cikara...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources